Pricing Log in Create free account

Belite Bio, Inc. Sponsored ADR (BLTE) vs Oruka Therapeutics, Inc. (ORKA)

Belite Bio, Inc. Sponsored ADR and Oruka Therapeutics, Inc. are both Biotechnology companies. Oruka Therapeutics, Inc. is the larger, with a market value of $6.4B against $5.8B — 1.1× the size. Across the 9 metrics below, Oruka Therapeutics, Inc. leads on 5 and Belite Bio, Inc. Sponsored ADR on 4.

Valuation

Metric BLTE ORKA Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 7.48 5.47 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (1.90%) (2.19%) (34.89%)
Free cash flow yield (1.16%) (1.66%) (24.52%)

Profitability

Metric BLTE ORKA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (18.30%) (50.12%)
Return on assets (21.60%) (17.76%) (45.60%)
Return on invested capital (9.55%) (40.22%) 0.00%

Growth

Metric BLTE ORKA Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (95.76%) 52.20% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLTE ORKA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 33.56 38.51 4.89
Net debt to EBITDA 5.88 2.65 1.01

Dividend

Metric BLTE ORKA Biotechnology median
Dividend yield — 0.00% 0.41%
Payout ratio — — —

Size

Metric BLTE ORKA Biotechnology median
Market cap 5.77b 6.36b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack